Mast Cell Sarcoma Mimicking Lymphoma or Metastatic Disease on 18F-FDG PET/CT.


Journal

Clinical nuclear medicine
ISSN: 1536-0229
Titre abrégé: Clin Nucl Med
Pays: United States
ID NLM: 7611109

Informations de publication

Date de publication:
08 Mar 2024
Historique:
medline: 8 3 2024
pubmed: 8 3 2024
entrez: 8 3 2024
Statut: aheadofprint

Résumé

We report an 18F-FDG PET/CT scan of a 47-year-old man diagnosed with diffuse mast cell sarcoma with lymph node, bone, liver, spleen, and lung involvement. This interesting image should remind colleagues to consider mast cell sarcoma as a rare differential diagnosis in patients with multiple, intensely hypermetabolic lesions in various organs and lymph nodes.

Identifiants

pubmed: 38456450
doi: 10.1097/RLU.0000000000005162
pii: 00003072-990000000-01005
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

Copyright © 2024 Wolters Kluwer Health, Inc. All rights reserved.

Déclaration de conflit d'intérêts

Conflicts of interest and sources of funding: none declared.

Références

Monnier J, Georgin-Lavialle S, Canioni D, et al. Mast cell sarcoma: new cases and literature review. Oncotarget. 2016;7:66299–66309.
Ryan RJ, Akin C, Castells M, et al. Mast cell sarcoma: a rare and potentially under-recognized diagnostic entity with specific therapeutic implications. Mod Pathol. 2013;26:533–543.
Valent P, Akin C, Hartmann K, et al. Updated diagnostic criteria and classification of mast cell disorders: a consensus proposal. Hema. 2021;5:e646.
Weiler CR, Butterfield J. Mast cell sarcoma: clinical management. Immunol Allergy Clin North Am. 2014;34:423–432.
Georgin-Lavialle S, Aguilar C, Guieze R, et al. Mast cell sarcoma: a rare and aggressive entity—report of two cases and review of the literature. J Clin Oncol. 2013;31:e90–e97.
Chen I, Liao J-B, Lin J-C, et al. Mast cell sarcoma of the retroperitoneum with concurrent systemic mastocytosis and an undisclosed associated hematologic neoplasm: a case report. Clin Pathol. 2022;15:2632010X221123539.
Singh A, Alkhateeb H, Pardanani A, et al. Mast cell sarcoma: 2 Mayo Clinic cases. Am J Hematol. 2022;97:1381–1383.
Matsumoto NP, Yuan J, Wang J, et al. Mast cell sarcoma: clinicopathologic and molecular analysis of 10 new cases and review of literature. Mod Pathol. 2022;35:865–874.
Djelbani-Ahmed S, Chandesris MO, Mekinian A, et al. FDG-PET/CT findings in systemic mastocytosis: a French multicentre study. Eur J Nucl Med Mol Imaging. 2015;42:2013–2020.

Auteurs

Florian Rosar (F)

From the Departments of Nuclear Medicine.

Samer Ezziddin (S)

From the Departments of Nuclear Medicine.

Jörg Thomas Bittenbring (JT)

Hematology, Oncology, Clinical Immunology, Rheumatology, Saarland University, Homburg, Germany.

Konstantinos Christofyllakis (K)

Hematology, Oncology, Clinical Immunology, Rheumatology, Saarland University, Homburg, Germany.

Caroline Burgard (C)

From the Departments of Nuclear Medicine.

Classifications MeSH